|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CELF1-DAPL1 (FusionGDB2 ID:15624) |
Fusion Gene Summary for CELF1-DAPL1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CELF1-DAPL1 | Fusion gene ID: 15624 | Hgene | Tgene | Gene symbol | CELF1 | DAPL1 | Gene ID | 10658 | 92196 |
Gene name | CUGBP Elav-like family member 1 | death associated protein like 1 | |
Synonyms | BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|NAB50|NAPOR|hNab50 | - | |
Cytomap | 11p11.2 | 2q24.1 | |
Type of gene | protein-coding | protein-coding | |
Description | CUGBP Elav-like family member 150 kDa nuclear polyadenylated RNA-binding proteinCUG RNA-binding proteinCUG triplet repeat RNA-binding protein 1CUG-BP- and ETR-3-like factor 1EDEN-BP homologRNA-binding protein BRUNOL-2bruno-like 2bruno-like protein | death-associated protein-like 1early epithelial differentiation-associated protein | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q92879 | . | |
Ensembl transtripts involved in fusion gene | ENST00000395290, ENST00000358597, ENST00000395292, ENST00000310513, ENST00000361904, ENST00000539455, ENST00000531165, ENST00000532048, | ENST00000309950, ENST00000409042, | |
Fusion gene scores | * DoF score | 23 X 21 X 14=6762 | 4 X 4 X 3=48 |
# samples | 35 | 5 | |
** MAII score | log2(35/6762*10)=-4.27202318906105 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/48*10)=0.0588936890535686 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: CELF1 [Title/Abstract] AND DAPL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CELF1(47585903)-DAPL1(159672217), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CELF1 | GO:0006376 | mRNA splice site selection | 11158314 |
Hgene | CELF1 | GO:0043484 | regulation of RNA splicing | 16946708 |
Fusion gene breakpoints across CELF1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across DAPL1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | TCGA-EM-A3ST-11A | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
Top |
Fusion Gene ORF analysis for CELF1-DAPL1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000395290 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000395290 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-3CDS | ENST00000358597 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000358597 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-3CDS | ENST00000395292 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000395292 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-3CDS | ENST00000310513 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000310513 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-3CDS | ENST00000361904 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000361904 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-3CDS | ENST00000539455 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000539455 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-3CDS | ENST00000531165 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000531165 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-3CDS | ENST00000532048 | ENST00000309950 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
intron-intron | ENST00000532048 | ENST00000409042 | CELF1 | chr11 | 47585903 | - | DAPL1 | chr2 | 159672217 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CELF1-DAPL1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CELF1-DAPL1 |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CELF1 | . |
FUNCTION: RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre-mRNAs. Activates SM exon 5 inclusion by antagonizing the repressive effect of PTB. Promotes exclusion of exon 11 of the INSR pre-mRNA. Inhibits, together with HNRNPH1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Increases translation and controls the choice of translation initiation codon of CEBPB mRNA. Increases mRNA translation of CEBPB in aging liver (By similarity). Increases translation of CDKN1A mRNA by antagonizing the repressive effect of CALR3. Mediates rapid cytoplasmic mRNA deadenylation. Recruits the deadenylase PARN to the poly(A) tail of EDEN-containing mRNAs to promote their deadenylation. Required for completion of spermatogenesis (By similarity). Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK and to Bruno response elements (BREs). Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. Binds to AU-rich sequences (AREs or EDEN-like) localized in the 3'-UTR of JUN and FOS mRNAs. Binds to the IR RNA. Binds to the 5'-region of CDKN1A and CEBPB mRNAs. Binds with the 5'-region of CEBPB mRNA in aging liver. May be a specific regulator of miRNA biogenesis. Binds to primary microRNA pri-MIR140 and, with CELF2, negatively regulates the processing to mature miRNA (PubMed:28431233). {ECO:0000250, ECO:0000269|PubMed:10536163, ECO:0000269|PubMed:11124939, ECO:0000269|PubMed:11158314, ECO:0000269|PubMed:12649496, ECO:0000269|PubMed:12799066, ECO:0000269|PubMed:14726956, ECO:0000269|PubMed:16601207, ECO:0000269|PubMed:16946708, ECO:0000269|PubMed:28431233}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CELF1-DAPL1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CELF1-DAPL1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CELF1-DAPL1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CELF1-DAPL1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |